Profile
Kevin B. Bacon was the founder of Actimis Pharmaceuticals, Inc. (founded in 2004, Chief Scientific Officer) and Axikin Pharmaceuticals, Inc. (founded in 2008, President, Director & Chief Scientific Officer).
Current jobs include Chief Executive Officer at Abcentra, Inc. (since 2020), President, Chief Executive Officer & Director at Sequoia Vaccines, Inc. (since 2023), and President, Chief Executive Officer & Director at Sequoia Sciences, Inc. Former jobs include Chief Executive Officer at Raft Pharmaceuticals LLC (2018-2020), Associate Director at Neurocrine Biosciences, Inc., Principal at Bayer AG (1999-2004), Vice President-Respiratory Diseases Research at Bayer HealthCare AG (1999-2004), and Principal at DNAX Research, Inc. Education includes a doctorate from the University of London and an undergraduate degree from King's College London.
Kevin B. Bacon active positions
| Companies | Position | Start |
|---|---|---|
Abcentra, Inc.
Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Chief Executive Officer | 15/06/2020 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Develops and sells vaccines & small molecules for treating urinary tract and bacterial infections & cancers | Chief Executive Officer | 01/04/2023 |
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines for the treatment of bacterial infections and cancers | Chief Executive Officer | - |
Former positions of Kevin B. Bacon
| Companies | Position | End |
|---|---|---|
Raft Pharmaceuticals LLC | Chief Executive Officer | 01/01/2020 |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Founder | 01/02/2018 |
Axikin Pharmaceuticals, Inc.
Axikin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics | Founder | 01/01/2017 |
| BAYER AG | Corporate Officer/Principal | 01/01/2004 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01/01/2004 |
Training of Kevin B. Bacon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Axikin Pharmaceuticals, Inc.
Axikin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines for the treatment of bacterial infections and cancers | Health Technology |
Abcentra, Inc.
Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Commercial Services |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Develops and sells vaccines & small molecules for treating urinary tract and bacterial infections & cancers | Health Technology |
Raft Pharmaceuticals LLC |
- Stock Market
- Insiders
- Kevin B. Bacon
















